Skip to main content

Table 4 Distribution of study outcomes at baseline and endline, by treatment group and effect estimates of past-year intimate partner violence (Per protocol Analysis) (N = 934)

From: Gender norms and economic empowerment intervention to reduce intimate partner violence against women in rural Côte d’Ivoire: a randomized controlled pilot study

 

Treatment type

Baseline N (%)

Endline N (%)

Adjusted OR,q95% CI

p-value

Physical and/or Sexual IPV

VSLA Only (Comparison)a

93 (22.1)

78 (21.0)

--

--

 

VSLA + GDGb (Low adherence)

64 (22.9)

63 (24.6)

1.19 (0.69, 2.05)

0.64

 

VSLA + GDGc (High adherence)

55 (23.5)

37 (16.3)

0.64 (0.35, 1.16)l

0.14

Physical IPV

VSLA Only (Comparison)a

65 (15.4)

55 (14.8)

--

--

 

VSLA + GDGb (Low adherence)

44 (15.8)

36 (14.1)

0.93 (0.49, 1.77)

0.82

 

VSLA + GDGc (High adherence)

36 (15.4)

17 (7.5)

0.45 (0.21, 0.94)l

0.04

Sexual IPV

VSLA Only (Comparison)a

44 (10.5)

53 (14.3)

--

--

 

VSLA + GDGb (Low adherence)

38 (13.6)

41 (16.0)

0.85 (0.44, 1.64)

0.63

 

VSLA + GDGc (High adherence)

33 (14.1)

27 (11.9)

0.54 (0.27, 1,10)l

0.11

Economic abuse

VSLA Only (Comparison)d

113 (27.4)

128 (34.6)

--

--

 

VSLA + GDGe (Low adherence)

99 (36.3)

56 (21.9)

0.31 (0.18, 0.52)

<0.0001

 

VSLA + GDGf (High adherence)

64 (28.1)

48 (21.2)

0.47 (0.27, 0.81)m

0.01

  

Mean (SD)

Mean (SD)

Adjusted β (95% CI)

p-value

Justification for wife beating

VSLA Only (Comparison)g

4.5 (4.3)

4.0 (4.0)

  
 

VLSA + GDG (Low adherence)h

5.2 (4.5)

3.9 (4.3)

-0.19 (-1.13, 0.74)n

0.69

 

VSLA + GDGi (High adherence)

4.5 (4.2)

2.9 (3.6)

-1.14 (-2.01, -0.28)

0.01

Ability to refuse sex

VSLA Only (Comparison)j

5.7 (1.7)

6.2 (1.5)

  
 

VLSA + GDG (Low adherence)h

5.7 (1.8)

6.3 (1.6)

0.07 (-0.32, 0.46)o

0.72

 

VSLA + GDG (High adherence)k

5.7 (1.7)

6.4 (1.4)

0.12 (-0.24, 0.48)

0.50

  1. aTotal n for VLSA only at baseline is 416; Total n for VLSA only at endline is 368.
  2. bTotal n for VSLA + GDG low adherence at baseline is 275; Total n for VLSA + GDG low adherence at endline is 252.
  3. cTotal n for VSLA + GDG high adherence at baseline is 232; Total n for VSLA + GDG high adherence at endline is 226.
  4. dTotal n for VLSA only at baseline is 408; Total n for VLSA only at endline is 367.
  5. eTotal n for VSLA + GDG low adherence at baseline is 270; Total n for VSLA + GDG low adherence at endline is 252.
  6. fTotal n for VSLA + GDG high adherence at baseline is 227; Total n for VSLA + GDG high adherence at endline is 226.
  7. gTotal n for VLSA only at baseline is 419; Total n for VLSA only at endline is 401.
  8. hTotal n for VSLA + GDG low adherence at baseline is 278; Total n for VSLA + GDG low adherence at endline is 273.
  9. iTotal n for VSLA + GDG high adherence at baseline is 233; Total n for VSLA + GDG high adherence at endline is 229.
  10. jTotal n for VLSA only at baseline is 421; Total n for VLSA only at endline is 403.
  11. kTotal n for VSLA + GDG high adherence at baseline is 234; Total n for VSLA + GDG high adherence at endline is 230.
  12. lTotal observations in model is 1769/1868.
  13. mTotal observations in model is 1750/1868.
  14. nTotal observations in model is 1812/1868.
  15. oTotal observations in model is 1818/1868.
  16. pAdjusted for categorical number of pregnancies and religion as they were statistically associated with adherence.